Compare BLCO & R Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | R |
|---|---|---|
| Founded | 1853 | 1933 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Rental/Leasing Companies |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.5B |
| IPO Year | 2022 | N/A |
| Metric | BLCO | R |
|---|---|---|
| Price | $17.21 | $193.94 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 10 |
| Target Price | $17.31 | ★ $204.67 |
| AVG Volume (30 Days) | ★ 350.5K | 350.2K |
| Earning Date | 02-18-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | N/A | ★ 10.62 |
| EPS | N/A | ★ 11.82 |
| Revenue | $4,976,000,000.00 | ★ $12,679,000,000.00 |
| Revenue This Year | $8.06 | $2.54 |
| Revenue Next Year | $5.79 | $3.74 |
| P/E Ratio | ★ N/A | $16.16 |
| Revenue Growth | ★ 6.23 | 1.68 |
| 52 Week Low | $10.45 | $125.54 |
| 52 Week High | $18.14 | $200.53 |
| Indicator | BLCO | R |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 57.27 |
| Support Level | $17.02 | $185.02 |
| Resistance Level | $17.55 | $193.11 |
| Average True Range (ATR) | 0.41 | 4.40 |
| MACD | -0.02 | -0.78 |
| Stochastic Oscillator | 51.83 | 68.05 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.